content_copy International Treatments - Vitro Biopharma

Clinical Safety Profile

To date, within our IRB-approved international clinical trials and FDA-authorized eINDS, Vitro has treated approximately 200 patients with AlloRx® in multiple indications with no severe adverse events and minimal side effects. There is also evidence of efficacy as we continue to treat patients, both international and through eINDS.